Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 6,901–6,925 of 7,816 matching trials · page 277 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Meditation or Education for Alzheimer Caregivers NCT00558402 Meditation; Education; Respite only Runs in: United States · 1 site |
PHASE2 other |
COMPLETED | 72 | Oregon Health and Science University OTHER |
2014-10-29 |
|
Dual Task Aerobic Exercise for Older Adults With Cognitive Impairment (HM2) NCT01572311 Exercise Intervention; Exercise Control Runs in: Canada · 1 site |
NA other |
COMPLETED | 44 | Parkwood Hospital, London, Ontario OTHER |
2014-10-28 |
|
Evaluating Cerebrospinal Fluid Biomarkers in Alzheimer's, Progressive Supranuclear Palsy Subjects, and Controls NCT01348061 Runs in: United States · 3 sites |
NA other |
COMPLETED | 16 | KineMed INDUSTRY |
2014-10-24 |
|
Memantine Plus Es-citalopram in Elderly Depressed Patients With Cognitive Impairment NCT01876823 es-citalopram; Memantine Runs in: United States · 1 site |
PHASE2|PHASE3 symptomatic-cholinergic |
COMPLETED | 60 | New York State Psychiatric Institute OTHER |
2014-10-24 |
|
The Use of EEG in Alzheimer's Disease, With and Without Scopolamine - A Pilot Study NCT02273895 Scopolamine |
NA other |
COMPLETED | 29 | Mentis Cura INDUSTRY |
2014-10-24 |
|
EEG Classification System for Dementia NCT02273921 EEG recording |
NA other |
UNKNOWN | 2,000 | Mentis Cura INDUSTRY |
2014-10-24 |
|
Evaluation of Electronic Florbetapir (18F) Interpretation Training in Japanese Physicians NCT02029547 Florbetapir (18F) Runs in: Japan · 1 site |
NA other |
WITHDRAWN | 0 | Avid Radiopharmaceuticals INDUSTRY |
2014-10-23 |
|
The Effects of White Noise on Agitated Behaviors and Cortisol Level in Saliva Among the Patients With Dementia NCT02271321 White noise Runs in: Taiwan · 1 site |
NA other |
UNKNOWN | 84 | Chang Bing Show Chwan Memorial Hospital OTHER |
2014-10-22 |
|
Effects of Memantine on Magnetic Resonance (MR) Spectroscopy in Subjects at Risk for Alzheimer's Disease NCT00933608 memantine; Placebo Runs in: United States · 1 site |
PHASE4 symptomatic-cholinergic |
COMPLETED | 17 | NYU Langone Health OTHER |
2014-10-21 |
|
Comparison of Effects of Intravenous Midazolam and Ketamine on Emergence Agitation NCT02256358 Midazolam; Ketamine |
NA other |
COMPLETED | 68 | Inje University OTHER |
2014-10-20 |
|
Combined Cognitive and Physical Exercises Through Computer Games in Elderly: The LLM Project NCT02267499 LLM training |
NA other |
COMPLETED | 322 | Aristotle University Of Thessaloniki OTHER |
2014-10-20 |
|
Capacity Assessment in Persons With Alzheimer's Disease NCT01190800 Runs in: France · 1 site |
NA other |
COMPLETED | 400 | Assistance Publique - Hôpitaux de Paris OTHER |
2014-10-15 |
|
Alzheimer Disease : Rehabilitation's Intervention at Home NCT01689948 Home rehabilitation therapy Runs in: France · 1 site |
NA other |
TERMINATED | 17 | Nantes University Hospital OTHER |
2014-10-15 |
|
A Study to Assess Effects of Clarithromycin on Pharmacokinetics of JNJ-54861911 in Healthy Male Participants NCT02197884 JNJ-54861911, 25 mg; Itraconazole 200 mg; Clarithromycin 500 mg Runs in: Belgium · 1 site |
PHASE1 other |
COMPLETED | 13 | Janssen Research & Development, LLC INDUSTRY |
2014-10-15 |
|
Efficacy and Safety Study of Shenwu Capsule NCT01451749 Shenwu Capsule; Donepezil Runs in: China · 1 site |
PHASE3 symptomatic-cholinergic |
COMPLETED | 324 | North China Pharmaceutical Group Corporation INDUSTRY |
2014-10-10 |
|
Study of Biomarkers That Predict the Evolution of Huntington's Disease NCT01412125 Huntington patient evaluation; Healthy subject evaluation Runs in: France · 1 site |
NA other |
UNKNOWN | 1,800 | Assistance Publique - Hôpitaux de Paris OTHER |
2014-10-09 |
|
A Study to Evaluate Bioavailability, Food Effect, Safety and Tolerability of a Solid Dosage Formulation of JNJ-54861911 in Healthy Older Male Participants NCT02260700 JNJ-54861911 (Treatment A); JNJ-54861911 (Treatment B); JNJ-5486191... Runs in: Belgium · 1 site |
PHASE1 other |
COMPLETED | 12 | Janssen Research & Development, LLC INDUSTRY |
2014-10-09 |
|
The PACO Study ("Personnalité Alzheimer COmportement") NCT01297140 questioning Runs in: France · 1 site |
NA other |
UNKNOWN | 252 | Hospices Civils de Lyon OTHER |
2014-10-03 |
|
Hyperbaric Oxygen Therapy for Mild Cognitive Impairment NCT02085330 Hyperbaric oxygen therapy Runs in: Israel · 1 site |
NA other |
UNKNOWN | 60 | Assaf-Harofeh Medical Center OTHER_GOV |
2014-10-02 |
|
Imaging Characteristics of Florbetapir 18F in Patients With Frontotemporal Dementia, Alzheimer's Disease and Normal Controls. NCT01890343 florbetapir 18F; 18F-FDG Runs in: United Kingdom · 1 site |
PHASE2 other |
COMPLETED | 34 | Avid Radiopharmaceuticals INDUSTRY |
2014-09-29 |
|
Animal-assisted or Robot-assisted Interventions in Health Promotion for Elderly With Dementia NCT01998490 Animal-assisted activity; Robot-assisted activity Runs in: Norway · 15 sites |
NA other |
COMPLETED | 88 | Norwegian University of Life Sciences OTHER |
2014-09-29 |
|
Animal-assisted Interventions in Health Promotion for Elderly With Dementia NCT02008630 Animal-assisted activity; Animal-assisted therapy Runs in: Norway · 21 sites |
NA other |
COMPLETED | 122 | Norwegian University of Life Sciences OTHER |
2014-09-29 |
|
HIV-1 Specific Immune Responses in Thai Individuals With HIV Dementia NCT00777426 Runs in: Thailand · 1 site |
NA other |
COMPLETED | 60 | SEARCH Research Foundation OTHER |
2014-09-26 |
|
Efficacy and Safety of Talsaclidine (Free Base) in Patients With Mild to Moderate Dementia of Alzheimer Type NCT02249351 Talsaclidine; Placebo |
PHASE2 other |
TERMINATED | 54 | Boehringer Ingelheim INDUSTRY |
2014-09-26 |
|
Efficacy and Safety of Talsaclidine in Patients With Mild to Moderate Dementia of Alzheimer Type NCT02249403 Talsaclidine 6 mg; Talsaclidine 12 mg; Talsaclidine 24 mg; Talsacli... |
PHASE2 other |
COMPLETED | 362 | Boehringer Ingelheim INDUSTRY |
2014-09-26 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial